These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
608 related articles for article (PubMed ID: 15168138)
1. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature. Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138 [TBL] [Abstract][Full Text] [Related]
2. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453 [TBL] [Abstract][Full Text] [Related]
3. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas. Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191 [TBL] [Abstract][Full Text] [Related]
4. Proliferation and progesterone receptor status in benign meningiomas are not age dependent. Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201 [TBL] [Abstract][Full Text] [Related]
5. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas. Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071 [TBL] [Abstract][Full Text] [Related]
6. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma. Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512 [TBL] [Abstract][Full Text] [Related]
7. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas. Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125 [TBL] [Abstract][Full Text] [Related]
10. Is progesteron receptor status really a prognostic factor for intracranial meningiomas? Iplikcioglu AC; Hatiboglu MA; Ozek E; Ozcan D Clin Neurol Neurosurg; 2014 Sep; 124():119-22. PubMed ID: 25036873 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior. Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942 [TBL] [Abstract][Full Text] [Related]
12. MUC4 expression in meningiomas: under-recognized immunophenotype particularly in meningothelial and angiomatous subtypes. Matsuyama A; Jotatsu M; Uchihashi K; Tsuda Y; Shiba E; Haratake J; Hisaoka M Histopathology; 2019 Jan; 74(2):276-283. PubMed ID: 30112770 [TBL] [Abstract][Full Text] [Related]
13. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry. Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919 [TBL] [Abstract][Full Text] [Related]
14. Progesterone Receptor Is Responsible for Benign Biology of Skull Base Meningioma. Kuroi Y; Matsumoto K; Shibuya M; Kasuya H World Neurosurg; 2018 Oct; 118():e918-e924. PubMed ID: 30031954 [TBL] [Abstract][Full Text] [Related]
15. Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression. Nagashima G; Asai J; Suzuki R; Fujimoto T Brain Tumor Pathol; 2001; 18(1):1-5. PubMed ID: 11517968 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II. Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806 [TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231 [TBL] [Abstract][Full Text] [Related]
18. Angiomatous meningioma: a clinicopathologic study of 38 cases. Hasselblatt M; Nolte KW; Paulus W Am J Surg Pathol; 2004 Mar; 28(3):390-3. PubMed ID: 15104303 [TBL] [Abstract][Full Text] [Related]
19. Association of apparent diffusion coefficient with Ki-67 proliferation index, progesterone-receptor status and various histopathological parameters, and its utility in predicting the high grade in meningiomas. Bozdağ M; Er A; Ekmekçi S Acta Radiol; 2021 Mar; 62(3):401-413. PubMed ID: 32397733 [TBL] [Abstract][Full Text] [Related]
20. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Abramovich CM; Prayson RA Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]